FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1542823104> ?p ?o ?g. }

• W1542823104 endingPage "328" @default.
• W1542823104 startingPage "321" @default.
• W1542823104 abstract "Skin testing with a suspected drug has been reported to be helpful in determining the cause of cutaneous adverse drug reactions (CADR). Many isolated reports of positive drug skin tests are published, but without detailed information concerning the clinical features of the CADR and the method used in performing drug skin tests, such data are not very informative. A working party of the European Society of Contact Dermatitis (ESCD) for the study of skin testing in investigating cutaneous adverse drug reactions, has proposed the herein-reported guidelines for performing skin testing in CADR in order to standardize these procedures. In each reported case, the imputability of each drug taken at the onset of the CADR and a highly detailed description and characterization of the dermatitis need to be given. Drug skin tests are performed 6 weeks to 6 months after complete healing of the CADR. Drug patch tests are performed according to the methods used in patch testing in studying contact dermatitis. The commercialized form of the drug used by the patient is tested diluted at 30% pet. (pet.) and/or water (aq.). The pure drug is tested diluted at 10% in pet. or aq. In severe CADR, drug patch tests are performed at lower concentrations. It is also of value to test on the most affected site of the initial CADR. Drug prick tests are performed on the volar forearm skin with the commercialized form of the drug, but with sequential dilutions in cases of urticaria. Intradermal tests (IDT) are performed with sterile sequential dilutions (10-4, 10-3, 10-2, 10-1) of a pure sterile or an injectable form of the suspected drug with a small volume of 0.04 ml. Drug skin tests need to be read at 20 min and also later at D2 and D4 for patch tests, at D1 for prick tests and IDT. All these tests also need to be read at 1 week. The success of skin tests varies with the drug tested, with a high % of positive results, for example, with betalactam antibiotics, pristinamycin, carbamazepine and tetrazepam on patch testing, or with betalactam antibiotics and heparins on delayed readings of IDT. The results of drug skin tests also depend on the clinical features of the CADR. The use of appropriate control patients is necessary to avoid false-positive results." @default.
• W1542823104 created "2016-06-24" @default.
• W1542823104 creator A5002183309 @default.
• W1542823104 creator A5005238750 @default.
• W1542823104 creator A5030183942 @default.
• W1542823104 creator A5054083544 @default.
• W1542823104 date "2001-12-01" @default.
• W1542823104 modified "2023-10-18" @default.
• W1542823104 title "Guidelines for performing skin tests withdrugs in the investigation of cutaneous adverse drug reactions" @default.
• W1542823104 cites W1964956727 @default.
• W1542823104 cites W1971532617 @default.
• W1542823104 cites W1974902977 @default.
• W1542823104 cites W1977686632 @default.
• W1542823104 cites W1977790581 @default.
• W1542823104 cites W1977992497 @default.
• W1542823104 cites W1979125477 @default.
• W1542823104 cites W1979260113 @default.
• W1542823104 cites W1985366298 @default.
• W1542823104 cites W1986828546 @default.
• W1542823104 cites W1988499763 @default.
• W1542823104 cites W1989064114 @default.
• W1542823104 cites W1992818710 @default.
• W1542823104 cites W2006215766 @default.
• W1542823104 cites W2023706681 @default.
• W1542823104 cites W2029916735 @default.
• W1542823104 cites W2036103062 @default.
• W1542823104 cites W2038173607 @default.
• W1542823104 cites W2041006051 @default.
• W1542823104 cites W2042894170 @default.
• W1542823104 cites W2043302793 @default.
• W1542823104 cites W2043881292 @default.
• W1542823104 cites W2047971517 @default.
• W1542823104 cites W2049942972 @default.
• W1542823104 cites W2050436387 @default.
• W1542823104 cites W2052535249 @default.
• W1542823104 cites W2063237125 @default.
• W1542823104 cites W2064963754 @default.
• W1542823104 cites W2064972652 @default.
• W1542823104 cites W2067561788 @default.
• W1542823104 cites W2070339579 @default.
• W1542823104 cites W2081403537 @default.
• W1542823104 cites W2083554666 @default.
• W1542823104 cites W2083667045 @default.
• W1542823104 cites W2088443485 @default.
• W1542823104 cites W2091884920 @default.
• W1542823104 cites W2097187403 @default.
• W1542823104 cites W2107884181 @default.
• W1542823104 cites W2117293835 @default.
• W1542823104 cites W2155152715 @default.
• W1542823104 cites W4231276614 @default.
• W1542823104 doi "https://doi.org/10.1034/j.1600-0536.2001.450601.x" @default.
• W1542823104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11846746" @default.
• W1542823104 hasPublicationYear "2001" @default.
• W1542823104 type Work @default.
• W1542823104 sameAs 1542823104 @default.
• W1542823104 citedByCount "456" @default.
• W1542823104 countsByYear W15428231042012 @default.
• W1542823104 countsByYear W15428231042013 @default.
• W1542823104 countsByYear W15428231042014 @default.
• W1542823104 countsByYear W15428231042015 @default.
• W1542823104 countsByYear W15428231042016 @default.
• W1542823104 countsByYear W15428231042017 @default.
• W1542823104 countsByYear W15428231042018 @default.
• W1542823104 countsByYear W15428231042019 @default.
• W1542823104 countsByYear W15428231042020 @default.
• W1542823104 countsByYear W15428231042021 @default.
• W1542823104 countsByYear W15428231042022 @default.
• W1542823104 countsByYear W15428231042023 @default.
• W1542823104 crossrefType "journal-article" @default.
• W1542823104 hasAuthorship W1542823104A5002183309 @default.
• W1542823104 hasAuthorship W1542823104A5005238750 @default.
• W1542823104 hasAuthorship W1542823104A5030183942 @default.
• W1542823104 hasAuthorship W1542823104A5054083544 @default.
• W1542823104 hasConcept C140764562 @default.
• W1542823104 hasConcept C141071460 @default.
• W1542823104 hasConcept C16005928 @default.
• W1542823104 hasConcept C197934379 @default.
• W1542823104 hasConcept C203014093 @default.
• W1542823104 hasConcept C207480886 @default.
• W1542823104 hasConcept C2778091633 @default.
• W1542823104 hasConcept C2778750689 @default.
• W1542823104 hasConcept C2779515644 @default.
• W1542823104 hasConcept C2780035454 @default.
• W1542823104 hasConcept C2780542314 @default.
• W1542823104 hasConcept C2993432071 @default.
• W1542823104 hasConcept C3020497150 @default.
• W1542823104 hasConcept C71924100 @default.
• W1542823104 hasConcept C98274493 @default.
• W1542823104 hasConceptScore W1542823104C140764562 @default.
• W1542823104 hasConceptScore W1542823104C141071460 @default.
• W1542823104 hasConceptScore W1542823104C16005928 @default.
• W1542823104 hasConceptScore W1542823104C197934379 @default.
• W1542823104 hasConceptScore W1542823104C203014093 @default.
• W1542823104 hasConceptScore W1542823104C207480886 @default.
• W1542823104 hasConceptScore W1542823104C2778091633 @default.
• W1542823104 hasConceptScore W1542823104C2778750689 @default.
• W1542823104 hasConceptScore W1542823104C2779515644 @default.
• W1542823104 hasConceptScore W1542823104C2780035454 @default.

• next